Want to join the conversation?
$ENDP's 1Q16 revenue grew 35% versus 1Q15 due to Auxilium and Par acquisitions. US Branded revenue grew 8.5% due to higher net sales in Specialty Pharma and Branded Other. US Generic revenue grew 63.4% due to higher net sales in US Generics Base and Sterile Injectables. International Pharma revenue fell 2% due to foreign currency rate fluctuations.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.